Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.

× No keyword cloud information.

35 in total

1. Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase.

Authors: M E Gnegy; A Lucchelli; E Costa
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1977-12 Impact factor: 3.000

2. Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain.

Authors: R Ohman; M Larsson; I M Nilsson; J Engel; A Carlsson
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1977-09 Impact factor: 3.000

3. Bromperidol, a new butyrophenone neuroleptic: a review.

Authors: B Dubinsky; J L McGuire; C J Niemegeers; P A Janssen; H S Weintraub; B E McKenzie
Journal: Psychopharmacology (Berl) Date: 1982 Impact factor: 4.530

4. Genetic regulation of neurotransmitter enzymes and receptors: relationship to the inheritance of psychiatric disorders.

Authors: R D Ciaranello; R E Boehme
Journal: Behav Genet Date: 1982-02 Impact factor: 2.805

5. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.

Authors: S Chiu; R K Mishra
Journal: Naunyn Schmiedebergs Arch Pharmacol Date: 1980-08 Impact factor: 3.000

6. Differential reversal of various dopamine antagonists by anticholinergics in Sidman avoidance: possible relationship to adrenergic blockade.

Authors: J M Liebman; R Neale; L Noreika; A Braunwalder
Journal: Psychopharmacology (Berl) Date: 1981 Impact factor: 4.530

Dopamine receptor binding: differentiation of agonist and antagonist states with 3H-dopamine and 3H-haloperidol.

1. Correlation between drug-induced supersensitivity of dopamine dependent striatal mechanisms and the increase in striatal content of the Ca2+ regulated protein activator of cAMP phosphodiesterase.

2. Neurometabolic and behavioural effects of haloperidol in relation to drug levels in serum and brain.

3. Bromperidol, a new butyrophenone neuroleptic: a review.

4. Genetic regulation of neurotransmitter enzymes and receptors: relationship to the inheritance of psychiatric disorders.

5. Effects of dopaminergic and cholinergic drugs. naloxone and l-prolyl-leucyl-glycinamide on LSD-induced catalepsy.

6. Differential reversal of various dopamine antagonists by anticholinergics in Sidman avoidance: possible relationship to adrenergic blockade.

7. 8-[3H]hydroxy-2-(di-n-propylamino) tetralin binding sites in goldfish retina.

8. Dopamine receptor binding in inbred mice: strain differences in mesolimbic and nigrostriatal dopamine binding sites.

9. Estimating the effect of endogenous dopamine on baseline [(11) C]-(+)-PHNO binding in the human brain.

10. Fifty years chlorpromazine: a historical perspective.